GDM: Insulin with or Without Metformin?
Part of paid clinical trials in Charlottesville, Virginia.
- Sponsor
- University of Virginia
- Study ID
- NCT06781775
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Gestational Diabetes
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 50 Years
- Healthy Volunteers
- Not accepted
Interventions
- Metformin + Insulin — DRUGPregnant women who have have gestational diabetes and have uncontrolled blood sugar with metformin alone will stay on metformin and add insulin.
- Insulin — DRUGPregnant women who have have gestational diabetes and have uncontrolled blood sugar with metformin alone will stop on metformin and add insulin.
Study Details
This will be a randomized trial of patients with gestational diabetes who start hypoglycemic therapy with metformin but eventually require insulin. It will examine whether continuing metformin when adding insulin versus discontinuing metformin when insulin is added is beneficial. The investigators hypothesize that continuing metformin will reduce the needed insulin dosage and improve maternal and neonatal outcomes in these patients.
Key Dates
- Start date
- Dec 12, 2024
- Status verified
- Dec 2024
- Primary completion
- May 1, 2026
- Completion
- May 1, 2027
Study Design
- Enrollment
- 130 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Metformin + InsulinPregnant women with gestational diabetes who have uncontrolled blood sugar on metformin alone will be started on insulin and will stay on metformin.
- Active Comparator: InsulinPregnant women with gestational diabetes who have uncontrolled blood sugar on metformin along will be started on insulin and metformin will be discontinued.
Primary Outcome Measure
To determine if metformin reduces amount of insulin in patients with gestational diabetes who already require insulin [ Time Frame: From enrollment into study until delivery, maximum 20 weeks ]
Central Contacts
- Amanda R Urban, MS4344093100
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Virginia | Charlottesville | Virginia | 22903 | Christopher Ennen, MD |
Find similar trials in Charlottesville, VA
By research site
Related Studies
- Immediate Postpartum Glucose Tolerance TestingRecruiting · MemorialCare Health System · Long Beach, California
- iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational DiabetesRecruiting · The University of Texas Health Science Center, Houston · Houston, Texas
- DETERMINE: Detemir vs NPHPHASE2 · Recruiting · University of California, Los Angeles · Los Angeles, California
- Intensive Glycemic Targets in Overweight and Obese Women With Gestational DiabetesRecruiting · Indiana University · Birmingham, Alabama